Surveillance Surveys for Reemergent Trachoma in Formerly Endemic Districts in Nepal From 2 to 10 Years After Mass Drug Administration Cessation

Authors:

Abstract
Trachoma, a chronic conjunctivitis caused by Chlamydia trachomatis, is the leading infectious cause of blindness worldwide, although impressive strides toward elimination are being achieved.1 The World Health Organization (WHO)2 has set a goal of elimination of trachoma as a public health problem by 2020. Elimination has been defined as a follicular trachoma (TF) prevalence less than 5% among children aged 1 to 9 years at the district level and as a trachomatous trichiasis (TT) case unknown to the health system prevalence less than 2 cases per 1000 population 15 years and older at the district level.3 As more endemic districts within countries reach the elimination goal, they must undergo surveillance surveys for potential reemergence. The WHO recommends that at least 2 years after cessation of mass drug administration (MDA) a surveillance prevalence survey should be undertaken in the district to reconfirm a less than 5% level of TF and a sustainable reduction of TT.3

This publication has 12 references indexed in Scilit: